Migraine and Stroke

From a Western clinical standpoint, migraine and stroke intersect through epidemiology, mechanisms, and management decisions. Large meta-analyses and nationwide cohorts consistently show that migraine with aura carries about a twofold increased relative risk of ischemic stroke, with the signal strongest in women younger than 45. The absolute risk in this age group remains low, but it is meaningfully modified by other exposures—most notably smoking and estrogen-containing contraceptives. The risk increment for hemorrhagic stroke is smaller and less consistent, observed primarily in women with active aura. Mechanistically, migraine is a neurovascular disorder. Cortical spreading depression (CSD)—a wave of neuronal and glial depolarization—underlies the aura and creates transient perfusion and metabolic mismatch. In parallel, evidence points to endothelial dysfunction, altered nitric oxide signaling, platelet activation, and a proinflammatory, prothrombotic milieu in some patients. PFO is more prevalent among those with aura and provides a conduit for paradoxical emboli, explaining cryptogenic events in a subset. Rarely, aura persists beyond 60 minutes with an infarct in the corresponding territory—termed migrainous infarction. Clinically, the first priority is accurate triage. Aura typically evolves gradually with positive symptoms (scintillations, paresthesias) that spread over minutes and may migrate between modalities, whereas TIA or stroke deficits often start abruptly, are negative (loss of function), and peak at onset. Yet features can overlap, so sudden new focal deficits, atypical or first/worst headaches, prolonged aura, motor weakness, or symptoms in pregnancy/postpartum warrant emergency stroke evaluation with imaging and neurology input. For prevention, clinicians focus on rigorous control of blood pressure, lipids, diabetes, and smoking cessation. In women with aura, guidelines advise careful selection of contraception, often favoring progestin-only or nonhormonal options in those with additional vascular risks. For acute migraine in patients with cerebrovascular disease or high risk, non-vasoconstrictive agents (ditans, gepants) are favored over triptans or ergots. Antiplatelet therapy is reserved for standard vascular indications rather than for migraine alone. Ongoing research is clarifying the long-term vascular safety of CGRP-pathway therapies and the clinical utility of PFO evaluation beyond cryptogenic stroke.

Traditional and integrative frameworks offer a complementary lens. In Traditional Chinese Medicine (TCM), migraine patterns commonly reflect Liver yang rising, wind, phlegm, and blood stasis—internal dynamics that can also culminate in ‘Wind-stroke,’ a sudden disruption of qi and blood in the channels. Ayurveda similarly points to vata aggravation with rakta (blood) involvement. These models emphasize the terrain—stress reactivity, diet, sleep, and constitution—rather than a single trigger, aligning with modern recognition that vascular tone, autonomic balance, and inflammation shape both migraine expression and cerebrovascular vulnerability. Therapeutically, acupuncture seeks to calm internal wind, harmonize Liver and Gallbladder channels, and regulate autonomic tone. Modern trials support acupuncture as a prophylactic option for migraine and as an adjunct in stroke rehabilitation for selected outcomes such as spasticity and functional recovery. Herbal strategies often employ wind-subduing and blood-activating formulas—such as Tian Ma Gou Teng Yin (Gastrodia and Uncaria) and Chuanxiong-containing prescriptions—to ease headache, support endothelial function, and modulate blood pressure. Mind–body practices (tai chi, qigong, meditation) are used to reduce stress, improve sleep, and gently lower blood pressure, potentially affecting both migraine frequency and vascular risk. In integrative care, these approaches are combined with Western risk-factor management: tobacco cessation, dietary pattern changes (e.g., Mediterranean-style), weight and sleep optimization, and tailored pharmacotherapy. Importantly, traditional practitioners also note red flags—sudden severe headache, new neurological deficits, or headaches during pregnancy/postpartum—prompting urgent biomedical evaluation. While the language differs—qi stagnation and blood stasis versus endothelial dysfunction and hypercoagulability—both traditions converge on the principle that stabilizing the internal environment reduces episodic attacks and lowers the chance of catastrophic vascular events. Collaboration between licensed acupuncturists/herbalists and medical clinicians can support individualized, safe plans, particularly around herb–drug interactions and contraindications in patients with established cerebrovascular disease.